- Release Date: 06/11/23 08:29
- Summary: Lead-in phase completed for ph2/3 trial in Breast Cancer
- Price Sensitive: Yes
- Download Document 280.55KB
- Forums
- ASX - By Stock
- Ann: Lead-in phase completed for ph2/3 trial in Breast Cancer
IMM
immutep limited
Add to My Watchlist
4.17%
!
23.0¢

Ann: Lead-in phase completed for ph2/3 trial in Breast Cancer
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $337.6M |
Open | High | Low | Value | Volume |
24.0¢ | 24.0¢ | 23.0¢ | $244.5K | 1.043M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 392012 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 126850 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 337175 | 0.230 |
26 | 845468 | 0.225 |
17 | 475222 | 0.220 |
6 | 96683 | 0.215 |
5 | 35289 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 81779 | 2 |
0.240 | 149319 | 6 |
0.245 | 239528 | 5 |
0.250 | 38080 | 2 |
0.255 | 70000 | 3 |
Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |